Important Notice: Our web hosting provider recently started charging us for additional visits, which was unexpected. In response, we're seeking donations. Depending on the situation, we may explore different monetization options for our Community and Expert Contributors. It's crucial to provide more returns for their expertise and offer more Expert Validated Answers or AI Validated Answers. Learn more about our hosting issue here.

Is enhancing the quality of COFEPRIS enough for Mexican companies to go global?

0
Posted

Is enhancing the quality of COFEPRIS enough for Mexican companies to go global?

0

Another big difference with India is that in that country the government was very interested in developing the pharmaceutical industry. Therefore, since the 1980s the government has been putting in place the right set of incentives for firms to move internationally and invest in R&D. Interestingly enough we started working in biotechnology in Mexico long before any Indian, Chinese or Korean company. Although Mexico was one step ahead in biotechnology in the 1980’s, we could say it has been left behind… In order to understand this phenomenon, it is necessary to take a look at the country’s history in the area of patent legislation. In 1976 the law on “Invenciones y Marcas” identified 3 areas as strategic for the country’s development: national security, food and healthcare. According to this legislation patents could not be obtained in any of these areas, which basically meant that for example drugs and APIs could not be patented. Then, in 1987, the government published a decree by whic

Related Questions

What is your question?

*Sadly, we had to bring back ads too. Hopefully more targeted.

Experts123